ZIPBIO
LIVE

Serial Number

98801864

Owner

Zip Bio Inc.

Attorney

Aaron D. Hendelman

Filing Date

Oct 15, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ZIPBIO Trademark

Serial Number: 98801864

ZIPBIO is a trademark filed by Zip Bio Inc. on October 15, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Zip Bio Inc.

125 Coolidge Street
Brookline, MA 02446

Entity Type: 03

Trademark Details

Filing Date

October 15, 2024

Registration Date

Not Registered

Published for Opposition

May 13, 2025

Goods & Services

pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; therapeutic proteins for medical use for the treatment of ophthalmological diseases and disorders; biologics for medical use, namely, biological preparations for the treatment of ophthalmological diseases and disorders; pharmaceutical preparations, biological preparations, clinical medical reagents and therapeutic proteins for use in the treatment of genetic-based and cell-based diseases and disorders; pharmaceutical preparations, biological preparations, clinical medical reagents and therapeutic proteins for use in gene therapy, cell therapy, gene diagnosis, cell diagnosis, gene testing and cell testing; pharmaceutical preparations, biological preparations, clinical medical reagents and therapeutic proteins for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations, biological preparations, clinical medical reagents and therapeutic proteins for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; vaccines for human use; biological therapeutic preparations for use as vaccines

research and development relating to pharmaceuticals for the treatment of ophthalmological diseases and disorders; scientific research and development in connection with therapeutic proteins for use in pharmaceutical products; medical research and product development in the fields of biotechnology, drug discovery, pharmaceuticals, scientific research, biological preparations and protein therapeutics; research and development relating to pharmaceutical preparations, biological preparations and therapeutic proteins for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; research and development in the field of gene therapy, gene diagnosis and gene testing; biological research; chemical research; medical and scientific research, namely, conducting clinical trials for others; scientific research; scientific laboratory services

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 8, 2026 EXRA
SOU EXTENSION 1 GRANTED
Jan 8, 2026 EX1G
SOU EXTENSION 1 FILED
Jan 7, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 7, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 8, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 13, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 13, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 7, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 14, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 28, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 28, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 26, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 26, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 26, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 15, 2024 NWOS
NEW APPLICATION ENTERED
Oct 15, 2024 NWAP